Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Rapizzi

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Endocrine-Related Cancer|January 14, 2012
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patientsValentina Piccini, Elena Rapizzi, Alessandra Bacca, et al.
The Journal of Pathology|May 29, 2020
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomasPaal W Wallace, Catleen Conrad, Sascha Brückmann, et al.
Human Molecular Genetics|February 19, 2013
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosisIñaki Comino-Méndez, Aguirre A de Cubas, Carmen Bernal, et al.
Endocrine-Related Cancer|October 30, 2023
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomasMinghao Li, Susan Richter, Hermine Mohr, et al.
Frontiers in Endocrinology|February 10, 2023
Co-occurrence of mutations in <i>NF1</i> and other susceptibility genes in pheochromocytoma and paragangliomaSara Mellid, Eduardo Gil, Rocío Letón, et al.
Cancers|November 27, 2021
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in ItalyLetizia Canu, Soraya Puglisi, Paola Berchialla, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 17, 2018
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patientsBruna Calsina, Maria Currás-Freixes, Alexandre Buffet, et al.
JAMA|December 16, 2010
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomasLi Yao, Francesca Schiavi, Alberto Cascon, et al.
Cancers|October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/ParagangliomaMaría Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)Thomas G Papathomas, Lindsey Oudijk, Alexandre Persu, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Endocrine-Related Cancer|January 14, 2012
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patientsValentina Piccini, Elena Rapizzi, Alessandra Bacca, et al.
The Journal of Pathology|May 29, 2020
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomasPaal W Wallace, Catleen Conrad, Sascha Brückmann, et al.
Human Molecular Genetics|February 19, 2013
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosisIñaki Comino-Méndez, Aguirre A de Cubas, Carmen Bernal, et al.
Endocrine-Related Cancer|October 30, 2023
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomasMinghao Li, Susan Richter, Hermine Mohr, et al.
Frontiers in Endocrinology|February 10, 2023
Co-occurrence of mutations in <i>NF1</i> and other susceptibility genes in pheochromocytoma and paragangliomaSara Mellid, Eduardo Gil, Rocío Letón, et al.
Cancers|November 27, 2021
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in ItalyLetizia Canu, Soraya Puglisi, Paola Berchialla, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 17, 2018
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patientsBruna Calsina, Maria Currás-Freixes, Alexandre Buffet, et al.
JAMA|December 16, 2010
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomasLi Yao, Francesca Schiavi, Alberto Cascon, et al.
Cancers|October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/ParagangliomaMaría Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)Thomas G Papathomas, Lindsey Oudijk, Alexandre Persu, et al.
Pageof 7